ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Ann Surg Oncol. 2022 Dec;29(Suppl 3):616-617. doi: 10.1245/s10434-022-11448-w.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Clinical Trial, Phase II

MeSH terms

  • Adenocarcinoma* / drug therapy
  • Cell-Free Nucleic Acids*
  • Cytoreduction Surgical Procedures
  • Deoxyribose
  • Humans
  • Prospective Studies
  • Standard of Care


  • Deoxyribose
  • Cell-Free Nucleic Acids